Side Navigation

R&D

Core Technology

Medicinal Chemistry

Our unique fragment-based drug discovery approach utilizing 20 unique scaffolds with its own drug-likeness.
- Successfully applied to antibiotics and anti-coagulants programs.
- Expedited drug discovery period (avg 5 → 3 yrs).